This article has Open Peer Review reports available.
Keratitis caused by the recently described new species Aspergillus brasiliensis: two case reports
© Manikandan et al; licensee BioMed Central Ltd. 2010
Received: 21 October 2009
Accepted: 24 February 2010
Published: 24 February 2010
Human infections caused by Aspergillus brasiliensis have not yet been reported. We describe the first two known cases of fungal keratitis caused by Aspergillus brasiliensis.
A 49-year-old Indian Tamil woman agricultural worker came with pain and defective vision in the right eye for one month. Meanwhile, a 35-year-old Indian Tamil woman presented with a history of a corneal ulcer involving the left eye for 15 days. The fungal strains isolated from these two cases were originally suspected to belong to Aspergillus section Nigri based on macro- and micromorphological characteristics. Molecular identification revealed that both isolates represent A. brasiliensis.
The two A. brasiliensis strains examined in this study were part of six keratitis isolates from Aspergillus section Nigri, suggesting that this recently described species may be responsible for a significant proportion of corneal infections caused by black Aspergilli. The presented cases also indicate that significant differences may occur between the severities of keratitis caused by individual isolates of A. brasiliensis.
Certain Aspergillus species, mainly A. flavus, A. terreus, A. fumigatus and A. niger have long been regarded as important pathogens in eye infections, especially keratitis . Other members of the genus less frequently occurring in keratitis include A. glaucus, A. ochraceus and A. tamarii [1, 2]. The identification at the species level of Aspergillus strains causing keratomycosis would be of great importance since the pathogenic potential and antifungal susceptibilities may substantially vary between different species of the genus. Herein we report the first two known cases of fungal keratitis caused by the recently described species A. brasiliensis.
A 49-year-old, Indian Tamil woman agricultural worker came with pain and defective vision in the right eye for one month. The symptoms started after she was exposed to paddy husk. At the time of presentation she was using 5% topical natamycin and gatifloxacin eye drops prescribed by her ophthalmologist. She had no significant past ophthalmic history or medical history. On examination, the visual acuity in her right eye was 5/60. Slit lamp evaluation of the right eye revealed a full thickness corneal abscess involving the nasal 1/3rd of the cornea and the adjacent limbus with a localized thick exudation extending from the endothelial side on to the iris, partly covering the pupillary area. Routine microbiological workup did not reveal any organism in smear studies, but a black Aspergillus was identified from culture after four days (designated as strain 832/06). Based on clinical impression, topical itraconazole and 200 mg oral ketoconazole twice a day were added to natamycin, but the ulcer perforated by the fourth day. Topical natamycin was replaced by 0.15% amphotericin B and a therapeutic corneal transplantation was performed. Part of the iris, which was covered by the exudation, was found to be necrotic and was excised. The anterior chamber was washed with 80 μg/ml amphotericin B. Topical amphotericin B, clotrimazole and oral ketoconazole were continued post-operatively with topical ketorolac and 2% cyclosporine A drops. The graft remained clear initially but with severe fibrinous reaction in aqueous. On 12 days, the infection seemed to be eradicated but extensive peripheral anterior synechiae and post synechiae formed and a mature cataract developed. Ultrasonic B scan showed a clear vitreous. Cataract aspiration and synechiolysis were done after 14 days. Topical prednisolone acetate suspension was also started post-operatively.
By the 40th postoperative day, however, peripheral synechiae reappeared at the inferior 2/3rd circumference and the intraocular pressure (IOP) started to rise (the IOP spike was 46 mmHg). The glaucoma was controlled medically with 0.5% timolol and 2% Pilocarpine drops. Six months later, a penetrating optical graft was performed with synechiolysis. Though the graft remained clear for three months, the IOP started to rise with topical steroids, which needed enhanced medical therapy with Alphagan. However, the recalcitrant glaucoma necessitated a cyclodestructive procedure with Diode laser. Though the intraocular pressure was controlled, the graft failed to recover.
A 35-year-old Indian Tamil woman presented with a history of corneal ulcer involving the left eye for the past 15 days. She had been treated with 5% natamycin by her local ophthalmologist. She also gave a history of enucleation of the right eye following trauma sustained a year earlier. On examination, the vision in the left eye was 2/60. Slit lamp evaluation revealed a mild, central corneal ulcer, 2.2 × 3 mm in size involving the anterior 1/3rd of the stroma. Scarring was noted at the peripheral edges of the ulcer. Smears prepared from scrapings obtained from the base and the leading edges of the ulcer were negative but cultures revealed a black Aspergillus (designated as strain 138/07). She was advised to continue natamycin eye drops with itraconazole eye ointment. The ulcer healed in two weeks time with complete resolution of the infiltration. During follow-up after 10 months, our patient had a macular grade corneal scar with a best-corrected visual acuity of 6/18.
The E-test method (AB BIODISK, Solna, Sweden) for moulds was used to determine the minimal inhibitory concentration (MIC) values of the isolates to amphotericin B, fluconazole, ketoconazole, itraconazole and voriconazole according to the instructions of the manufacturer (Etest technical guide 10). The MIC of natamycin (5% suspension, Sun Pharmaceutical Ind. Ltd., Halol, India), econazole (2% suspension, Aurolab, Madurai, India) and clotrimazole (1% suspension, Aurolab, Madurai, India) were determined by the broth microdilution technique NCCLS M38-A .
MIC values (μg/ml) of antifungal drugs towards the two A. brasiliensis isolates
A. brasiliensis 832/06
A. brasiliensis 138/07
Living cultures from case 1 and case 2 were deposited in the Centraalbureau for Schimmelcultures (strain numbers: CBS 122724 and CBS 122723, respectively).
From Aspergillus section Nigri, only A. niger has been reported to date as a possible causative agent of fungal keratitis . In a study from North India, A. niger was found to be the most common among the Aspergillus species causing keratitis, in 64 out of 78 cases . However, the isolates in this previous study were identified on the basis of their macroscopic and microscopic morphology only, and the identifications were not confirmed by molecular techniques. Black Aspergilli are one of the most difficult groups in classification and identification . Molecular approaches revealed that there is a high biodiversity among them, but that taxa are difficult to be recognized solely on their phenotypic characters . In both cases described in this report, partial sequence analysis of the β-tubulin gene revealed that the isolates belong to the A. brasiliensis species. These two A. brasiliensis strains were part of six keratitis isolates from Aspergillus section Nigri, suggesting that this recently described species may be responsible for a significant proportion of corneal infections caused by black Aspergilli.
A. brasiliensis is a biseriate species closely related to A. niger and A. tubingensis. This new species is known from soil from Brazil, Australia, USA and the Netherlands, and from grape berries from Portugal, indicating a cosmopolitan distribution . A. brasiliensis can be distinguished from other black Aspergilli based on intergenic transcribed spacer region, β-tubulin and calmodulin gene sequences, by amplified fragment length polymorphism analysis, by extrolite profiles [3, 6] as well as by detecting sequence variations contained in an about 180-bp region of the calmodulin gene with the aid of fluorescence-based SSCP analysis by capillary electrophoresis . Isolates of this species were found to produce naphtho-γ-pyrones, tensidol A and B and pyrophen in common with A. niger and A. tubingensis, but also several unique compounds, justifying their treatment as representing a separate species . The type strain of the species, A. brasiliensis CBS 101740 was also shown to produce xylanase and thermostable beta-xylosidase activities .
Although natamycin inhibited the growth of the isolates in vivo at low concentration (1 μg/ml), use of this antifungal agent in monotherapy was not successful. This could possibly be due to poor ocular penetration . However, it has been reported that natamycin monotherapy is associated with a poor outcome in Aspergillus keratitis . In combination with itraconazole, the treatment was effective in case 2, where the strain was more sensitive for this triazole with a lower MIC value. Other clinical studies mentioned its efficacy in the treatment of corneal ulcers caused by Aspergillus spp [9, 11]. Case 1 was more complicated: the combined therapy (natamycin plus topical itraconazole and oral ketoconazole) did not resolve the problem. Therapeutic corneal transplantation and administraion of intracameral amphotericin B were needed to eradicate the infection.
The presented cases indicate that significant differences may occur between the severities of keratitis caused by individual isolates of A. brasiliensis. To the best of our knowledge, these cases of fungal keratitis are the first reports on the involvement of A. brasiliensis in human infections.
Written informed consent was obtained from our patients for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
This study was supported by the Indian National Science Academy and the Hungarian Academy of Sciences within the frames of the Indo-Hungarian bilateral exchange programme No. IA/INSA-HAS Project/2007 as well as by DST and TéT with the bilateral grant OMFB-00285/2008. LK is a grantee of the János Bolyai Research Scholarship (Hungarian Academy of Sciences).
- Manikandan P, Dóczi I, Kocsubé S, Varga J, Németh TM, Antal Z, Vágvölgyi C, Bhaskar M, Kredics L: Aspergillus species in human keratomycosis. Aspergillus in the genomic era. Edited by: Varga J, Samson R. 2008, Wageningen: Wageningen Academic Publishers, 293-328.Google Scholar
- Kredics L, Varga J, Kocsubé S, Dóczi I, Samson RA, Rajaraman R, Narendran V, Bhaskar M, Vágvölgyi C, Manikandan P: Case of keratitis caused by Aspergillus tamarii. J Clin Microbiol. 2007, 45: 3464-3467. 10.1128/JCM.00920-07.View ArticlePubMedPubMed CentralGoogle Scholar
- Varga J, Kocsubé S, Tóth B, Frisvad JC, Perrone G, Susca A, Meijer M, Samson RA: Aspergillus brasiliensis sp. nov., a biseriate black Aspergillus species with world-wide distribution. Int J Syst Evol Microbiol. 2007, 57: 1925-1932. 10.1099/ijs.0.65021-0.View ArticlePubMedGoogle Scholar
- National Committee for Clinical Laboratory Standards: Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard. 2002, NCCLS document M38-A. Wayne, PA: National Committee for Clinical Laboratory StandardsGoogle Scholar
- Chowdhary A, Singh K: Spectrum of fungal keratitis in North India. Cornea. 2005, 24: 8-15. 10.1097/01.ico.0000126435.25751.20.View ArticlePubMedGoogle Scholar
- Samson RA, Noonim P, Meijer M, Houbraken J, Frisvad JC, Varga J: Diagnostic tools to identify black Aspergilli. Stud Mycol. 2007, 59: 129-145.View ArticlePubMedPubMed CentralGoogle Scholar
- Susca A, Stea G, Perrone G: Rapid polymerase chain reaction (PCR)-single-stranded conformational polymorphism (SSCP) screening method for the identification of Aspergillus section Nigri species by the detection of calmodulin nucleotide variations. Food Addit Contam. 2007, 24: 1148-1153. 10.1080/02652030701551834.View ArticlePubMedGoogle Scholar
- Pedersen M, Lauritzen HK, Frisvad JC, Meyer AS: Identification of thermostable beta-xylosidase activities produced by Aspergillus brasiliensis and Aspergillus niger. Biotechnol Lett. 2007, 29: 743-748. 10.1007/s10529-007-9314-9.View ArticlePubMedGoogle Scholar
- Agarwal PK, Roy P, Das A, Banerjee A, Maity PK, Banerjee AR: Efficacy of topical and systemic itraconazole as a broad-spectrum antifungal agent in mycotic corneal ulcer. A preliminary study. Indian J Ophthalmol. 2001, 49: 173-176.PubMedGoogle Scholar
- Lalitha P, Prajna NV, Kabra A, Mahadevan K, Srinivarsan M: Risk factors for treatment outcome in fungal keratitis. Ophthalmology. 2006, 113: 526-530. 10.1016/j.ophtha.2005.10.063.View ArticlePubMedGoogle Scholar
- Kalavathy CM, Parmar P, Kaliamurthy J, Philip VR, Ramalingam MD, Jesudasan CA, Thomas PA: Comparison of topical itraconazole 1% with topical natamycin 5% for the treatment of filamentous fungal keratitis. Cornea. 2005, 24: 449-452. 10.1097/01.ico.0000151539.92865.3e.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.